交易 Ionis Pharmaceuticals, Inc. - IONS CFD
新增到我的最愛- 摘要
- 曆史數據
- 活動
- 盈虧控制
- 資産負債表
- 現金流
交易條件
價差 | 0.18 | ||||||||
多頭倉位隔夜費用
多頭隔夜費用
前往平台 | -0.026179% | ||||||||
空頭倉位隔夜費用
空頭隔夜費用
前往平台 | 0.003957% | ||||||||
隔夜費時間 | 21:00 (UTC) | ||||||||
最小成交量 | 1 | ||||||||
貨幣 | USD | ||||||||
保證金 | 5% | ||||||||
股票交易 | United States of America | ||||||||
交易委員會 | 0% |
*Information provided by Capital.com
Ionis Pharmaceuticals Inc ESG Risk Ratings
High Medium Low Negligible
“B”分數表示相對 ESG 表現良好,公開報告重要 ESG 數據的透明度高於平均水平。
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 拋售 | 自訂 | 變化 (%) | 打開 | 最高 | 最小 |
---|---|---|---|---|---|---|
Mar 28, 2024 | 43.26 | -1.18 | -2.66% | 44.44 | 44.50 | 43.13 |
Mar 27, 2024 | 44.59 | 0.43 | 0.97% | 44.16 | 44.75 | 43.65 |
Mar 26, 2024 | 44.03 | 0.37 | 0.85% | 43.66 | 44.68 | 43.53 |
Mar 25, 2024 | 43.84 | 1.58 | 3.74% | 42.26 | 43.93 | 42.13 |
Mar 22, 2024 | 42.62 | 0.88 | 2.11% | 41.74 | 42.83 | 41.74 |
Mar 21, 2024 | 42.64 | 0.37 | 0.88% | 42.27 | 43.79 | 42.26 |
Mar 20, 2024 | 42.71 | 1.27 | 3.06% | 41.44 | 42.73 | 40.27 |
Mar 19, 2024 | 41.93 | 1.39 | 3.43% | 40.54 | 42.60 | 40.53 |
Mar 18, 2024 | 41.81 | -0.44 | -1.04% | 42.25 | 42.61 | 41.80 |
Mar 15, 2024 | 42.48 | 0.76 | 1.82% | 41.72 | 42.56 | 41.68 |
Mar 14, 2024 | 41.96 | -0.89 | -2.08% | 42.85 | 43.13 | 41.61 |
Mar 13, 2024 | 43.06 | -0.26 | -0.60% | 43.32 | 43.79 | 42.77 |
Mar 12, 2024 | 42.92 | -0.13 | -0.30% | 43.05 | 43.31 | 42.70 |
Mar 11, 2024 | 43.15 | -0.23 | -0.53% | 43.38 | 44.49 | 43.10 |
Mar 8, 2024 | 43.77 | -1.05 | -2.34% | 44.82 | 45.17 | 43.77 |
Mar 7, 2024 | 44.58 | 0.34 | 0.77% | 44.24 | 44.94 | 43.64 |
Mar 6, 2024 | 44.23 | 0.36 | 0.82% | 43.87 | 44.65 | 43.49 |
Mar 5, 2024 | 44.09 | -0.23 | -0.52% | 44.32 | 44.89 | 43.87 |
Mar 4, 2024 | 44.78 | -0.14 | -0.31% | 44.92 | 45.24 | 44.38 |
Mar 1, 2024 | 45.36 | 0.77 | 1.73% | 44.59 | 46.03 | 44.59 |
Ionis Pharmaceuticals, Inc. Events
時間 (UTC) | 國家 | 事件 |
---|---|---|
Wednesday, May 1, 2024 | ||
時間 (UTC) 12:30 | 國家 US
| 事件 Q1 2024 Ionis Pharmaceuticals Inc Earnings Release Q1 2024 Ionis Pharmaceuticals Inc Earnings ReleaseForecast(預報) -返回 - |
Friday, May 31, 2024 | ||
時間 (UTC) 21:00 | 國家 US
| 事件 Ionis Pharmaceuticals Inc Annual Shareholders Meeting Ionis Pharmaceuticals Inc Annual Shareholders MeetingForecast(預報) -返回 - |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
總收入 | 587.367 | 810.456 | 729.264 | 1122.6 | 599.674 |
收入 | 587.367 | 810.456 | 729.264 | 1122.6 | 599.674 |
收入成本,共計 | 14.116 | 10.842 | 11.947 | 4.384 | 1.82 |
毛利 | 573.251 | 799.614 | 717.317 | 1118.21 | 597.854 |
總營業費用 | 997.558 | 849.269 | 901.346 | 822.912 | 661.046 |
銷售/一般/行政費用,總計 | 150.295 | 170.947 | 332.222 | 286.644 | 244.622 |
研究與開發 | 833.147 | 634.953 | 526.877 | 465.688 | 414.604 |
異常費用(收入) | 32.527 | 30.3 | 66.196 | 0 | |
營業收入 | -410.191 | -38.813 | -172.082 | 299.687 | -61.372 |
利息收入(費用),非經營淨值 | 9.876 | 10.798 | 37.592 | 39.765 | -14.602 |
其他,淨值 | -7.274 | -1.133 | -0.062 | -0.686 | -0.182 |
稅前淨收入 | -257.985 | -29.148 | -134.552 | 338.766 | -76.156 |
稅後淨收入 | -269.722 | -28.597 | -479.743 | 287.259 | -117.115 |
少數股東權益 | 0 | 0 | 35.48 | -9.116 | 58.756 |
未計算非常項目前的淨收益 | -269.722 | -28.597 | -444.263 | 278.143 | -58.359 |
淨收入 | -269.722 | -28.597 | -444.263 | 278.143 | 273.741 |
普通股股東可獲收益 (不含非經常性項目) | -269.722 | -28.597 | -444.263 | 278.143 | -58.359 |
普通股股東可獲收益 (含非經常性項目) | -269.722 | -28.597 | -444.263 | 278.143 | 273.741 |
攤薄調整 | 0 | ||||
攤薄淨收入 | -269.722 | -28.597 | -444.263 | 278.143 | 273.741 |
攤薄後加權平均股 | 141.848 | 141.021 | 139.612 | 153.164 | 134.056 |
扣除特別項目的每股攤薄盈利 | -1.90149 | -0.20279 | -3.18213 | 1.81598 | -0.43533 |
每股正常攤薄盈利 | -2.58703 | -0.05286 | -3.04106 | 2.18246 | -0.43533 |
非常規項目總計 | 332.1 | ||||
Gain (Loss) on Sale of Assets | 149.604 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
總收入 | 188.411 | 130.524 | 151.889 | 159.767 | 133.791 |
收入 | 188.411 | 130.524 | 151.889 | 159.767 | 133.791 |
收入成本,共計 | 2.537 | 1.343 | 3.686 | 1.515 | 4.745 |
毛利 | 185.874 | 129.181 | 148.203 | 158.252 | 129.046 |
總營業費用 | 267.306 | 244.672 | 359.908 | 218.921 | 219.305 |
銷售/一般/行政費用,總計 | 46.142 | 45.516 | 47.95 | 34.416 | 33.802 |
研究與開發 | 229.927 | 197.813 | 308.272 | 182.99 | 180.758 |
營業收入 | -78.895 | -114.148 | -208.019 | -59.154 | -85.514 |
利息收入(費用),非經營淨值 | 19.219 | 16.49 | 13.436 | 7.732 | -5.064 |
其他,淨值 | -17.772 | -15.285 | 0.649 | 4.713 | -12.297 |
稅前淨收入 | -77.448 | -112.943 | -44.33 | -46.709 | -102.875 |
稅後淨收入 | -85.29 | -124.323 | -52.43 | -46.992 | -105.135 |
少數股東權益 | 0 | ||||
未計算非常項目前的淨收益 | -85.29 | -124.323 | -52.43 | -46.992 | -105.135 |
淨收入 | -85.29 | -124.323 | -52.43 | -46.992 | -105.135 |
普通股股東可獲收益 (不含非經常性項目) | -85.29 | -124.323 | -52.43 | -46.992 | -105.135 |
普通股股東可獲收益 (含非經常性項目) | -85.29 | -124.323 | -52.43 | -46.992 | -105.135 |
攤薄淨收入 | -85.29 | -124.323 | -52.43 | -46.992 | -105.135 |
攤薄後加權平均股 | 143.098 | 142.735 | 142.046 | 141.95 | 141.794 |
扣除特別項目的每股攤薄盈利 | -0.59603 | -0.87101 | -0.36911 | -0.33105 | -0.74146 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常攤薄盈利 | -0.64735 | -0.87101 | -1.05369 | -0.33105 | -0.74146 |
異常費用(收入) | -11.3 | ||||
Gain (Loss) on Sale of Assets | 149.604 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流動資産總額 | 2202.69 | 2345.05 | 2130.71 | 2720.6 | 2207.89 |
現金和短期投資 | 1986.87 | 2114.97 | 1892.38 | 2499.54 | 2084.07 |
現金等價物 | 276.472 | 869.191 | 397.664 | 683.287 | 278.82 |
短期投資 | 1710.4 | 1245.78 | 1494.71 | 1816.26 | 1805.25 |
應收賬款總額,淨額 | 25.538 | 61.896 | 76.204 | 63.034 | 12.759 |
應收賬款 - 貿易,淨額 | 25.538 | 61.896 | 76.204 | 63.034 | 12.759 |
總庫存 | 22.033 | 24.806 | 21.965 | 18.18 | 8.582 |
其他流動資産,總計 | 168.254 | 143.374 | 140.163 | 139.839 | 102.473 |
總資産 | 2533.88 | 2611.69 | 2389.75 | 3233.11 | 2667.78 |
物業/廠房/設備,總計 - 淨額 | 255.838 | 196.069 | 181.077 | 166.251 | 132.16 |
物業/廠房/設備,總計 - 總額 | 343.554 | 298.722 | 240.264 | 193.634 | |
累計折舊,總計 | -87.716 | -102.653 | -74.013 | -61.474 | |
無形資産,淨額 | 29.005 | 27.937 | 25.674 | 24.032 | |
其他長期資産,總計 | 75.344 | 41.567 | 50.034 | 320.59 | 303.706 |
流動負債總額 | 311.561 | 240.55 | 598.898 | 273.005 | 280.294 |
應付賬款 | 17.921 | 11.904 | 17.199 | 16.067 | 28.66 |
預提費用 | 196.494 | 129.97 | 155.889 | 106.152 | 77.629 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
長期債務的當前部分/資本租賃 | 0.32 | 0.926 | 316.11 | 13.749 | |
其他流動負債,總計 | 96.826 | 97.75 | 109.7 | 150.786 | 160.256 |
負債總額 | 1960.99 | 1839.95 | 1646.47 | 1762.02 | 1619.7 |
長期債務總額 | 1182.72 | 1228.02 | 623.529 | 770.3 | 632.971 |
長期債務 | 1182.72 | 1228.02 | 623.529 | 770.3 | 632.971 |
資本租賃義務 | |||||
其他負債,總計 | 466.709 | 371.379 | 424.046 | 505.26 | 567.359 |
股權 | 572.887 | 771.737 | 743.282 | 1471.09 | 1048.08 |
普通股 | 0.142 | 0.141 | 0.14 | 0.14 | 0.138 |
額外實收資本 | 2059.85 | 1964.17 | 1895.52 | 2203.78 | 2047.25 |
留存收益(累計赤字) | -1429.62 | -1159.9 | -1131.31 | -707.534 | -967.293 |
其他權益,總計 | -57.48 | -32.668 | -21.071 | -25.29 | -32.016 |
總負債和股東權益 | 2533.88 | 2611.69 | 2389.75 | 3233.11 | 2667.78 |
已發行普通股總數 | 142.058 | 141.21 | 140.366 | 140.34 | 137.929 |
少數股權 | 213.453 | 139.081 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
流動資産總額 | 2584.65 | 2616.75 | 2542.62 | 2202.69 | 2152.13 |
現金和短期投資 | 2235.58 | 2385.39 | 2346.78 | 1986.87 | 1981.66 |
現金等價物 | 352.06 | 424.79 | 309.031 | 276.472 | 314.993 |
短期投資 | 1883.52 | 1960.6 | 2037.75 | 1710.4 | 1666.67 |
應收賬款總額,淨額 | 142.359 | 27.956 | 13.914 | 25.538 | 6.645 |
應收賬款 - 貿易,淨額 | 142.359 | 27.956 | 13.914 | 25.538 | 6.645 |
總庫存 | 25.634 | 25.538 | 22.2 | 22.033 | 20.645 |
其他流動資産,總計 | 181.075 | 177.872 | 159.724 | 168.254 | 143.173 |
總資産 | 2933.97 | 2971.13 | 2885.22 | 2533.88 | 2421.97 |
物業/廠房/設備,總計 - 淨額 | 245.238 | 268.352 | 264.306 | 255.838 | 180.806 |
無形資産,淨額 | 29.605 | ||||
其他長期資産,總計 | 104.083 | 86.025 | 78.296 | 75.344 | 59.434 |
流動負債總額 | 404.21 | 287.975 | 259.221 | 311.561 | 283.454 |
應付賬款 | 5.615 | 24.021 | 10.499 | 17.921 | 20.545 |
預提費用 | 152.749 | 134.067 | 130.862 | 189.279 | 158.412 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
長期債務的當前部分/資本租賃 | 9.952 | 8.903 | 8.239 | 7.535 | 4.97 |
其他流動負債,總計 | 235.894 | 120.984 | 109.621 | 96.826 | 99.527 |
負債總額 | 2618.51 | 2542.83 | 2398.65 | 1960.99 | 1827.61 |
長期債務總額 | 1279.29 | 1315.26 | 1184.38 | 1182.72 | 1249.5 |
長期債務 | 1279.29 | 1315.26 | 1184.38 | 1182.72 | 1249.5 |
其他負債,總計 | 935.01 | 939.592 | 955.054 | 466.709 | 294.656 |
股權 | 315.46 | 428.301 | 486.57 | 572.887 | 594.361 |
普通股 | 0.143 | 0.143 | 0.143 | 0.142 | 0.142 |
額外實收資本 | 2148 | 2118.31 | 2089.36 | 2059.85 | 2034.55 |
留存收益(累計赤字) | -1786.65 | -1639.24 | -1553.95 | -1429.62 | -1377.19 |
其他權益,總計 | -46.037 | -50.913 | -48.983 | -57.48 | -63.14 |
總負債和股東權益 | 2933.97 | 2971.13 | 2885.22 | 2533.88 | 2421.97 |
已發行普通股總數 | 143.393 | 143.167 | 143.023 | 142.058 | 142.017 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
淨收入/起跑線 | -269.722 | -28.597 | -479.743 | 287.259 | 214.985 |
經營活動産生的現金 | -274.37 | 30.799 | 35.892 | 345.627 | 602.906 |
經營活動産生的現金 | 14.328 | 15.487 | 13.365 | 12.54 | 10.706 |
Amortization | 2.415 | 2.352 | 2.064 | 1.912 | 1.822 |
Deferred Taxes | 0 | 0 | 341.729 | 0.911 | -290.516 |
非現金物品 | -28.962 | 155.375 | 232.032 | 211.806 | 166.484 |
已付現金利息 | 2.898 | 4.778 | 6.247 | 9.87 | 9.592 |
營運資金的變化 | 7.571 | -113.818 | -73.555 | -168.801 | 499.425 |
投資活動産生的現金 | -262.636 | 194.906 | 274.477 | -41.274 | -929.563 |
資本支出 | -15.721 | -11.955 | -35.12 | -30.905 | -13.608 |
其他投資現金流量項目,總計 | -246.915 | 206.861 | 309.597 | -10.369 | -915.955 |
融資活動産生的現金 | -55.295 | 245.933 | -596.609 | 100.021 | 475.865 |
融資現金流項目 | -10.982 | -168.954 | -558.097 | -138.354 | 0 |
股票的發行(報廢),淨額 | 6.373 | 101.317 | -38.512 | 141.375 | 475.865 |
債務的發行(退還),淨額 | -50.686 | 313.57 | 0 | 97 | 0 |
現金淨變化 | -592.719 | 471.527 | -285.623 | 404.467 | 149.19 |
Cash Taxes Paid | 5.01 | 0.038 | 25.855 | 9.041 | 0 |
外彙效應 | -0.418 | -0.111 | 0.617 | 0.093 | -0.018 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -124.323 | -269.722 | -217.292 | -170.3 | -65.165 |
Cash From Operating Activities | -133.992 | -274.37 | -74.175 | -49.746 | -31.65 |
Cash From Operating Activities | 2.604 | 14.328 | 11.301 | 7.484 | 3.701 |
Amortization | 0.607 | 2.415 | 1.805 | 1.197 | 0.592 |
Deferred Taxes | 0 | ||||
Non-Cash Items | 42.124 | -28.962 | 91.563 | 64.125 | 32.983 |
Cash Taxes Paid | 0.293 | 5.01 | 0.002 | 0.002 | 0.002 |
Cash Interest Paid | 0.089 | 2.898 | 2.204 | 1.544 | 0.594 |
Changes in Working Capital | -55.004 | 7.571 | 38.448 | 47.748 | -3.761 |
Cash From Investing Activities | -325.64 | -262.636 | -474.783 | -290.853 | -287.549 |
Capital Expenditures | -10.472 | -15.721 | -11.582 | -6.04 | -2.705 |
Other Investing Cash Flow Items, Total | -315.168 | -246.915 | -463.201 | -284.813 | -284.844 |
Cash From Financing Activities | 492.087 | -55.295 | -4.276 | -6.11 | -7.325 |
Financing Cash Flow Items | 489.566 | -10.982 | -10.217 | -9.572 | -9.173 |
Issuance (Retirement) of Stock, Net | 2.56 | 6.373 | 6.03 | 3.462 | 1.848 |
Foreign Exchange Effects | 0.104 | -0.418 | -0.964 | -0.565 | -0.154 |
Net Change in Cash | 32.559 | -592.719 | -554.198 | -347.274 | -326.678 |
Issuance (Retirement) of Debt, Net | -0.039 | -50.686 | -0.089 | 0 |
差價合約交易計算器
計算您的假設損益
交易佣金
0
- 1:1
槓桿
1:1
- 20
- 100
- 500
- 1000
- 10000
交易
交易規模(槓桿 x 投資):
打開
拋售
已賣出 做多
Industry: | Biotechnology & Medical Research (NEC) |
2855 Gazelle Court
CARLSBAD
CALIFORNIA 92010
US
盈虧控制
- Annual
- Quarterly
人們也觀看
還在尋找值得信賴的經紀商?
加入全球 580.000 多名交易者,選擇與 Capital.com 交易